Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
After you are diagnosed with skin lymphoma, your cancer care team will try to figure out if it has spread, and if so, how far.
This process is called staging.
The stage of a cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Knowing the stage of your skin lymphoma may help in deciding the best treatment.
The tests used to gather information for staging skin lymphoma include:
These tests are described in Tests for Lymphoma of the Skin.
The staging systems for skin lymphomas were developed by the International Society for Cutaneous Lymphomas (ISCL) and the European Organization for Research and Treatment of Cancer (EORTC).
There are 2 different staging systems:
These systems can be hard to understand. If you have questions about the stage of your lymphoma, ask your cancer care team to explain it to you in a way you understand. This can help you make choices about your treatment.
Mycosis fungoides (MF) and Sezary syndrome (SS) are staged based on 4 factors:
T1: Skin lesions can be small patches (flat lesions), papules (small bumps), and/or plaques (raised or lowered, flat lesions), but the lesions cover less than 10% of the skin surface.
T2: The patches, papules, and/or plaques cover 10% or more of the skin surface.
T3: At least one of the skin lesions is a tumor (a lesion growing deeper into the skin) that is at least 1 centimeter (cm) across (a little less than 1/2 an inch).
T4: The skin lesions have grown together to cover at least 80% of the skin surface.
N0: Lymph nodes are not enlarged and a lymph node biopsy is not needed.
N1: Lymph nodes are enlarged, but when biopsied the patterns of cells look normal or close to normal under the microscope.
N2: Lymph nodes are enlarged, and when biopsied the patterns of cells look more abnormal under the microscope.
N3: Lymph nodes are enlarged, and when biopsied the patterns of cells look very abnormal under the microscope.
NX: Lymph nodes are enlarged but haven’t been removed (biopsied) to be looked at under the microscope.
M0: The lymphoma cells have not spread to other organs.
M1: Lymphoma cells have spread to other organs, such as the liver or spleen.
B0: No more than 5% of lymphocytes in the blood are Sezary (lymphoma) cells.
B1: Low numbers of Sezary cells in the blood (more than in B0 but less than in B2).
B2: High number of Sezary cells in the blood.
Once the values for T, N, M, and B are known, they are combined to determine the overall stage of the lymphoma. This process is called stage grouping.
Mycosis fungoides (MF) and Sezary syndrome (SS) stages range from I (1) through IV (4).
As a rule, the lower the number, the less the cancer has spread.
Although each person’s cancer experience is unique, cancers with similar stages tend to have a similar outlook and are often treated in much the same way.
The staging system for types of skin lymphoma other than mycosis fungoides and Sezary syndrome is fairly new, and doctors are still trying to determine how useful it is.
The system is based on 3 factors:
For these lymphomas, only the T category is used at the time of diagnosis.
If parts of the body other than the skin (such as lymph nodes) are involved at the time of diagnosis, the lymphoma is not considered to be a skin lymphoma and is staged like regular non-Hodgkin lymphoma.
The N and M categories are only used if the lymphoma progresses (continues to grow) during treatment or comes back after treatment.
T1: There is only a single skin lesion.
T2: There are 2 or more lesions on the skin. These may be in a single body region or in 2 body regions that are next to each other.
T3: There are skin lesions in body regions that aren’t next to each other, or in at least 3 different body regions.
N0: No lymph nodes are enlarged or contain lymphoma cells.
N1: There are lymphoma cells in the lymph nodes that drain an area where skin contained lymphoma.
N2: One of the following is true:
N3: Lymph nodes deep inside the chest or abdomen contain lymphoma cells.
M0: No signs of lymphoma outside of the skin or lymph nodes.
M1: Lymphoma has spread to other organs or tissues.
This system does not assign an overall stage to the lymphoma, like the system for mycosis fungoides/Sezary syndrome does. Because this system is still fairly new, it’s not yet clear how well it can help predict a person’s prognosis (outlook).
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
American Joint Committee on Cancer. Primary Cutaneous Lymphomas. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 967-972.
Last Revised: May 19, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.